LBRX
LB Pharmaceuticals Inc Common Stock
NASDAQ: LBRX · HEALTHCARE · BIOTECHNOLOGY
$31.71
+3.66% today
Updated 2026-04-30
Market cap
$912.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.13
Dividend yield
—
52W range
$13 – $33
Volume
0.3M
LB Pharmaceuticals Inc Common Stock (LBRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $21.49M | $45.66M | $33.53M |
| Cash & equivalents | $21.40M | $14.98M | $22.98M |
| Current assets | $21.49M | $45.63M | $28.88M |
| Total liabilities | $50.30M | $80.13M | $128.09M |
| Current liabilities | $469000.00 | $2.61M | $8.11M |
| Long-term debt | $24.15M | — | — |
| Shareholder equity | $-28.81M | $-34.47M | $-94.55M |
| Retained earnings | $-34.95M | $-41.22M | $-104.32M |
| Accounts receivable | — | — | — |
| Inventory | — | — | — |
| Goodwill | — | — | — |